![Thomas Needham](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Needham
Direktor/Vorstandsmitglied bei
RENOVACOR, INC.
Profil
Mr. Thomas E.
Needham is a Chairman at Renovacor Holdings, Inc., an Independent Director at Renovacor, Inc., a Managing Director at LongView Ventures LLC, a Managing Director at Broadview Ventures Inc and a Chairman at Basking Biosciences, Inc. He is on the Board of Directors at Renovacor, Inc.
Mr. Needham was previously employed as a Chief Business Officer by Merrimack Pharmaceuticals, Inc., a Senior Vice President-Business Development by C4 Therapeutics, Inc., a President & Director by Trident Pharmaceuticals, Inc., a Co-Founder by Synthesis Capital, a Principal by Advent International Corp, a Vice President by GPC Biotech AG, a Vice President by GPC Biotech, Inc., a Principal by ImmuLogic Pharmaceutical Corp., and a President, Chief Executive Officer & Director by Spear Therapeutics Ltd. He also served on the board at Prexa Pharmaceuticals, Inc. and Kantum Pharma, Inc.
He received his undergraduate degree from Bowdoin College and an MBA from F.W.
Olin Graduate School of Business.
Aktive Positionen von Thomas Needham
| Unternehmen | Position | Beginn |
|---|---|---|
| RENOVACOR, INC. | Direktor/Vorstandsmitglied | 01.08.2019 |
Basking Biosciences, Inc.
 Basking Biosciences, Inc. BiotechnologyHealth Technology Develops reversible thrombolytic therapy | Vorsitzender | - |
Renovacor Holdings, Inc.
 Renovacor Holdings, Inc. BiotechnologyHealth Technology Develops transformative gene therapy | Vorsitzender | 01.01.2020 |
Broadview Ventures, Inc.
 Broadview Ventures, Inc. Investment ManagersFinance Broadview Ventures invests in companies located across the globe, primarily in North America, Europe and Israel. The firm targets companies operating in the fields of healthcare and technology sectors. It provides financing for seed and early-stage capital requirements. The firm makes follow-on investments. | Private Equity Investor | 01.03.2018 |
LongView Ventures LLC
 LongView Ventures LLC Investment ManagersFinance LongView Ventures invests in companies located in the United States. The firm focuses on the clinical-stage companies. It provides financing for early and later stage capital requirements. | Private Equity Investor | 01.01.2019 |
Ehemalige bekannte Positionen von Thomas Needham
| Unternehmen | Position | Ende |
|---|---|---|
| MERRIMACK PHARMACEUTICALS | Corporate Officer/Principal | 01.03.2018 |
| C4 THERAPEUTICS, INC. | Corporate Officer/Principal | 01.06.2017 |
Advent International LP
 Advent International LP Investment ManagersFinance Advent invests in companies located across the globe. The firm targets companies operating in the fields of business & financial services, healthcare, industrial and technology services. It provides financing for leveraged buyout, recapitalizations, growth and public to private transactions. It also acquires majority and minority ownership. | Private Equity Investor | 01.05.2007 |
GPC Biotech AG
 GPC Biotech AG Miscellaneous Commercial ServicesCommercial Services Discovers, develops and commercializes new anticancer drugs | Corporate Officer/Principal | 01.05.2003 |
| ░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Thomas Needham
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
87
Beziehungen ersten Grades
18
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 18 |
|---|---|
Advent International LP
Advent International LP Investment ManagersFinance Advent invests in companies located across the globe. The firm targets companies operating in the fields of business & financial services, healthcare, industrial and technology services. It provides financing for leveraged buyout, recapitalizations, growth and public to private transactions. It also acquires majority and minority ownership. | Finance |
ImmuLogic Pharmaceutical Corp.
 ImmuLogic Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Trident Pharmaceuticals, Inc.
 Trident Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel biologics for the treatment of autoimmune disorders | Health Technology |
Prexa Pharmaceuticals, Inc.
 Prexa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oral small molecule monoamine reuptake inhibitors | Health Technology |
GPC Biotech AG
GPC Biotech AG Miscellaneous Commercial ServicesCommercial Services Discovers, develops and commercializes new anticancer drugs | Commercial Services |
Merrimack Pharmaceuticals, Inc.
 Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes drugs for the treatment of immunological & autoimmune diseases and cancer | Health Technology |
GPC Biotech, Inc.
 GPC Biotech, Inc. Drugstore ChainsRetail Trade Develops anticancer drugs | Retail Trade |
Bowdoin College
 Bowdoin College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spear Therapeutics Ltd.
 Spear Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops cancer treatment drugs | Health Technology |
Broadview Ventures, Inc.
Broadview Ventures, Inc. Investment ManagersFinance Broadview Ventures invests in companies located across the globe, primarily in North America, Europe and Israel. The firm targets companies operating in the fields of healthcare and technology sectors. It provides financing for seed and early-stage capital requirements. The firm makes follow-on investments. | Finance |
Synthesis Capital
 Synthesis Capital Investment ManagersFinance Synthesis Capital invests in US and European-based companies. The firm targets companies operating in the fields of bio-pharmaceutical and medical technology sectors. It provides financing for seed, early and late stage capital requirements. | Finance |
F.W. Olin Graduate School of Business
 F.W. Olin Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
C4 Therapeutics, Inc.
 C4 Therapeutics, Inc. BiotechnologyHealth Technology Develops targeted protein degradation therapeutics for the treatment of cancer | Health Technology |
Kantum Pharma, Inc.
 Kantum Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel and receptor antagonist-based therapeutics for AKI diagnostic tests | Commercial Services |
Renovacor Holdings, Inc.
Renovacor Holdings, Inc. BiotechnologyHealth Technology Develops transformative gene therapy | Health Technology |
LongView Ventures LLC
LongView Ventures LLC Investment ManagersFinance LongView Ventures invests in companies located in the United States. The firm focuses on the clinical-stage companies. It provides financing for early and later stage capital requirements. | Finance |
Basking Biosciences, Inc.
Basking Biosciences, Inc. BiotechnologyHealth Technology Develops reversible thrombolytic therapy | Health Technology |
Renovacor, Inc.
 Renovacor, Inc. BiotechnologyHealth Technology Engages in research and development for precision gene therapies and genetically driven cardiovascular diseases | Health Technology |
